Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04214756 · ClinicalTrials.gov registry record

Methodist Acute Pancreatitis Protocol

A clinical trial of Acute Pancreatitis (AP), sponsored by Methodist Health System.

Active
Registry status
500
Enrollment target
1
Study location

NCT04214756 is a study of Acute Pancreatitis (AP) that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04214756, a study of Acute Pancreatitis (AP), is active but no longer recruiting, sponsored by Methodist Health System.

ACTIVE NOT RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this ongoing registry study is to optimize initial evaluation and treatment of patients with AP according to recommended guidelines, the Methodist Acute Pancreatitis Protocol (MAPP), which were implemented in January 2015.

Conditions Studied

Interventions

  • PROCEDURE Acute Pancreatitis

Study Locations (1)

Texas

  • Methodist Health System - Dallas

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2014-04-05
Est. Completion 2026-06

Sponsor

Methodist Health System

125 total trials

What the Registry Record Tells You About NCT04214756

The ClinicalTrials.gov registry entry for NCT04214756 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Pancreatitis (AP) appearing as the primary indexed condition, and to 1 intervention - of which Acute Pancreatitis is the first listed.

NCT04214756 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04214756 about?

NCT04214756 is a clinical study titled "Methodist Acute Pancreatitis Protocol". The overall goal of this ongoing registry study is to optimize initial evaluation and treatment of patients with AP according to recommended guidelines, the Methodist Acute Pancreatitis Protocol (MAPP), which were implemented in January 2015.

What is the current status of trial NCT04214756?

This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2014-04-05. Estimated completion is 2026-06.

What conditions does trial NCT04214756 study?

This clinical trial studies the following conditions: Acute Pancreatitis (AP).

What interventions are being tested in trial NCT04214756?

The interventions under investigation include: Acute Pancreatitis (PROCEDURE).

Who is sponsoring clinical trial NCT04214756?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04214756 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.